Conatus Pharmaceutic (CNAT)
Histogen completes tie-up with Conatus Pharma (NASDAQ:CNAT)
Histogen (HSTO) has finalized its merger with Conatus Pharmaceuticals (NASDAQ:CNAT). The combined company with do business under the Histogen name with shares trading under the HSTO ticker starting to
Best & Worst Performing Small Cap Stocks for May 21, 2020
XTNT – XTNT leads the way today as the best performing small cap stock, closing up 160.28%.
Leading Independent Proxy Advisory Firms Recommend Conatus Pharmaceuticals Shareholders Vote in Favor of its Merger with Histogen and the Required Reverse Stock Split
Best & Worst Performing Small Cap Stocks for May 14, 2020
SNNA – SNNA leads the way today as the best performing small cap stock, closing up 34.46%.
Histogen Publishes Preclinical Data on its HST 004 Spinal Disc Program
Histogen Receives US FDA IND Approval to Initiate Phase 1b/2a Trial of HST 001 in Androgenic Alopecia
Best & Worst Performing Small Cap Stocks for May 8, 2020
PTGX – PTGX leads the way today as the best performing small cap stock, closing up 83.70%.
The Conatus Pharmaceuticals Special Meeting of Stockholders Seeking Approval for Proposed Merger with Histogen Inc. will Reconvene on May 21, 2020
Best & Worst Performing Small Cap Stocks for May 5, 2020
PTLA – PTLA leads the way today as the best performing small cap stock, closing up 130.03%.
Conatus Pharmaceuticals Reports First Quarter 2020 Financial Results and Strategic Process Update
Histogen Announces Investigational Device Exemption Application for HST 002
Histogen Publishes New Preclinical Data on its HST 003 Orthopedic Program
Histogen Announces Investigational New Drug Application Amendment for HST 001
Conatus Pharmaceuticals Reports 2019 Financial Results and Strategic Process Update
Penny Stocks To Buy Right Now Or Avoid At All Costs?
Do These Make The Cut Of Penny Stocks To Buy Right Now?…
Histogen to Present at BIO CEO & Investor Conference
Histogen and Allergan Expand Cell Conditioned Media (CCM) Skin Care Partnership
Will These Penny Stocks Make Investors Money This Week?
Penny Stocks To Watch After News If there’s one thing that can…
Conatus to merge with Histogen
Conatus Pharmaceuticals (NASDAQ:CNAT) and privately held Histogen have agreed to merge in an all-stock transaction. Conatus shareholders will own ~26% of the combined company while Histogen investors